D Belpomme
Impact in
- Biophysics top 1%
- Electromagnetic Fields and Biological Effects
- Oncology top 5%
- Cancer Treatment and Pharmacology
Papers in
- Oncology 32
- Cancer Treatment and Pharmacology 8
-
- Lymphoma Diagnosis and Treatment 16
- Co-authors
- Philippe Irigaray (23 shared papers)Lennart Hardell (3 shared papers)Richard Clapp (4 shared papers)Luc Montagnier (3 shared papers)G Mathé (25 shared papers)J.A. Newby (2 shared papers)Howard D. Homesley (1 shared paper)Peter S. Rose (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (4 papers)Recent results in cancer research (4 papers)Reviews on Environmental Health (4 papers)Cancer (3 papers)Annals of Oncology (3 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
D Belpomme
95 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 152
- Biophysics 218
- Oncology 710
- Cancer Research 313
- Pathology and Forensic Medicine 340
- Health, Toxicology and Mutagenesis 253
Countries citing papers authored by D Belpomme
This map shows the geographic impact of D Belpomme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Belpomme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Belpomme more than expected).
Fields of papers citing papers by D Belpomme
This network shows the impact of papers produced by D Belpomme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Belpomme. The network helps show where D Belpomme may publish in the future.
Co-authors
The 25 scholars most cited alongside D Belpomme, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 365 | |
| 2 | 2007 | 239 | |
| 3 | 2007 | 187 | |
| 4 | 2018 | 152 | |
| 5 | 2009 | 90 | |
| 6 | 2000 | 87 | |
| 7 | 1996 | 81 | |
| 8 | 2007 | 76 | |
| 9 | 2007 | 70 | |
| 10 | 1977 | 65 | |
| 11 | 2015 | 64 | |
| 12 | 1993 | 58 | |
| 13 | 1995 | 58 | |
| 14 | 1993 | 54 | |
| 15 | Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine. | 1978 | 47 |
| 16 | 2014 | 46 | |
| 17 | 2009 | 41 | |
| 18 | T and B lymphocyte markers on the neoplastic cell of 20 patients with acute and 10 patients with chronic lymphoid leukemia. | 1974 | 39 |
| 19 | 1983 | 30 | |
| 20 | 2020 | 28 |
About D Belpomme
D Belpomme is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 102 papers that have together received 2.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (16 papers), Acute Lymphoblastic Leukemia research (11 papers), Immune Cell Function and Interaction (9 papers), Cancer Treatment and Pharmacology (8 papers), Electromagnetic Fields and Biological Effects (6 papers), Carcinogens and Genotoxicity Assessment (6 papers) and Air Quality and Health Impacts (5 papers). The work is most often cited by research in Biophysics (218 citations), Oncology (710 citations), Cancer Research (313 citations), Pathology and Forensic Medicine (340 citations) and Health, Toxicology and Mutagenesis (253 citations). D Belpomme has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Philippe Irigaray, Lennart Hardell, Richard Clapp, Luc Montagnier, G Mathé, J.A. Newby, Howard D. Homesley, Peter S. Rose, Ameda A. Manetta and Bernard Roullet. Their work appears in journals such as Biomedicine & Pharmacotherapy, Recent results in cancer research, Reviews on Environmental Health, Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.